124 related articles for article (PubMed ID: 20501854)
1. Breast cancer dormancy can be maintained by small numbers of micrometastases.
Willis L; Alarcón T; Elia G; Jones JL; Wright NA; Tomlinson IP; Graham TA; Page KM
Cancer Res; 2010 Jun; 70(11):4310-7. PubMed ID: 20501854
[TBL] [Abstract][Full Text] [Related]
2. Tumor cell dormancy: implications for the biology and treatment of breast cancer.
Fehm T; Mueller V; Marches R; Klein G; Gueckel B; Neubauer H; Solomayer E; Becker S
APMIS; 2008; 116(7-8):742-53. PubMed ID: 18834416
[TBL] [Abstract][Full Text] [Related]
3. Modeling growth kinetics and statistical distribution of oligometastases.
Withers HR; Lee SP
Semin Radiat Oncol; 2006 Apr; 16(2):111-9. PubMed ID: 16564446
[TBL] [Abstract][Full Text] [Related]
4. Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system.
Kahn HJ; Hanna WM; Chapman JA; Trudeau ME; Lickley HL; Mobbs BG; Murray D; Pritchard KI; Sawka CA; McCready DR; Marks A
Breast J; 2006; 12(4):294-301. PubMed ID: 16848838
[TBL] [Abstract][Full Text] [Related]
5. What can be learnt about disease progression in breast cancer dormancy from relapse data?
Willis L; Graham TA; Alarcón T; Alison MR; Tomlinson IP; Page KM
PLoS One; 2013; 8(5):e62320. PubMed ID: 23671591
[TBL] [Abstract][Full Text] [Related]
6. Tumor dormancy: elevated expression of stanniocalcins in late relapsing breast cancer.
Joensuu K; Heikkilä P; Andersson LC
Cancer Lett; 2008 Jun; 265(1):76-83. PubMed ID: 18355956
[TBL] [Abstract][Full Text] [Related]
7. The relevance of occult axillary micrometastasis in ductal carcinoma in situ: a clinicopathologic study with long-term follow-up.
Lara JF; Young SM; Velilla RE; Santoro EJ; Templeton SF
Cancer; 2003 Nov; 98(10):2105-13. PubMed ID: 14601079
[TBL] [Abstract][Full Text] [Related]
8. Tumor dormancy and surgery-driven interruption of dormancy in breast cancer: learning from failures.
Demicheli R; Retsky MW; Hrushesky WJ; Baum M
Nat Clin Pract Oncol; 2007 Dec; 4(12):699-710. PubMed ID: 18037874
[TBL] [Abstract][Full Text] [Related]
9. Circulating tumor cells in patients with breast cancer dormancy.
Meng S; Tripathy D; Frenkel EP; Shete S; Naftalis EZ; Huth JF; Beitsch PD; Leitch M; Hoover S; Euhus D; Haley B; Morrison L; Fleming TP; Herlyn D; Terstappen LW; Fehm T; Tucker TF; Lane N; Wang J; Uhr JW
Clin Cancer Res; 2004 Dec; 10(24):8152-62. PubMed ID: 15623589
[TBL] [Abstract][Full Text] [Related]
10. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization.
Riethdorf S; Pantel K
Pathobiology; 2008; 75(2):140-8. PubMed ID: 18544969
[TBL] [Abstract][Full Text] [Related]
11. Relative microvessel area of the primary tumour, and not lymph node status, predicts the presence of bone marrow micrometastases detected by reverse transcriptase polymerase chain reaction in patients with clinically non-metastatic breast cancer.
Benoy IH; Salgado R; Elst H; Van Dam P; Weyler J; Van Marck E; Scharpé S; Vermeulen PB; Dirix LY
Breast Cancer Res; 2005; 7(2):R210-9. PubMed ID: 15743502
[TBL] [Abstract][Full Text] [Related]
12. Integrins in breast cancer dormancy.
Pontier SM; Muller WJ
APMIS; 2008; 116(7-8):677-84. PubMed ID: 18834411
[TBL] [Abstract][Full Text] [Related]
13. Does surgery for breast cancer induce angiogenesis and thus promote metastasis?
Park Y; Kitahara T; Takagi R; Kato R
Oncology; 2011; 81(3-4):199-205. PubMed ID: 22067898
[TBL] [Abstract][Full Text] [Related]
14. Primary lung cancer vs metastatic breast cancer: a probabilistic approach.
Vollmer RT
Am J Clin Pathol; 2009 Sep; 132(3):391-5. PubMed ID: 19687315
[TBL] [Abstract][Full Text] [Related]
15. Prediction of the long-term survival in breast cancer patients according to the present oncological status.
Hatteville L; Mahe C; Hill C
Stat Med; 2002 Aug; 21(16):2345-54. PubMed ID: 12210619
[TBL] [Abstract][Full Text] [Related]
16. Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18.
Fisher ER; Wang J; Bryant J; Fisher B; Mamounas E; Wolmark N
Cancer; 2002 Aug; 95(4):681-95. PubMed ID: 12209710
[TBL] [Abstract][Full Text] [Related]
17. Tumour dormancy: findings and hypotheses from clinical research on breast cancer.
Demicheli R
Semin Cancer Biol; 2001 Aug; 11(4):297-306. PubMed ID: 11513565
[TBL] [Abstract][Full Text] [Related]
18. ErbB2 overexpression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I-III breast cancer patients.
Braun S; Schlimok G; Heumos I; Schaller G; Riethdorf L; Riethmüller G; Pantel K
Cancer Res; 2001 Mar; 61(5):1890-5. PubMed ID: 11280743
[TBL] [Abstract][Full Text] [Related]
19. Occult micrometastases in axillary lymph nodes predict subsequent distant metastases in stage I breast cancer: a case-control study with 15-year follow-up.
Susnik B; Frkovic-Grazio S; Bracko M
Ann Surg Oncol; 2004 Jun; 11(6):568-72. PubMed ID: 15150071
[TBL] [Abstract][Full Text] [Related]
20. Chromosome 17-mediated dormancy of AT6.1 prostate cancer micrometastases.
Chekmareva MA; Kadkhodaian MM; Hollowell CM; Kim H; Yoshida BA; Luu HH; Stadler WM; Rinker-Schaeffer CW
Cancer Res; 1998 Nov; 58(21):4963-9. PubMed ID: 9810006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
